Skip to content

Changes

View changes from to


On April 19, 2024 at 1:08:55 PM UTC, Gravatar Sitti Salmiah:
  • Updated description of Percentage of children age 12-23 months who received Measles vaccine from

    ###Definition: * __Percentage of children age 12-23 months who received Measles vaccine__ refers to proportion of children in that age group who have gotten at least one dose of a measles-containing vaccine. * This statistic is a key indicator used by UNICEF and World Health Organization (WHO) to track measles immunization coverage and assess the effectiveness of childhood vaccination programs. Higher coverage rates translate to better herd immunity and lower chances of measles outbreaks ###Unit of Measure: * Percent (%) ###Year: * 2007, 2012 ###Source: * BKKBN - IDHS ###SDG Indicator: * __3.3__ By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases ###CPAP Outcome: * Child Survival and Development ###CPAP Output: * 1.5 EPI/Malaria/HIV
    to
    ###Definition: * __Percentage of children age 12-23 months who received Measles vaccine__ refers to proportion of children in that age group who have gotten at least one dose of a measles-containing vaccine. * This statistic is a key indicator used by UNICEF and World Health Organization (WHO) to track measles immunization coverage and assess the effectiveness of childhood vaccination programs. Higher coverage rates translate to better herd immunity and lower chances of measles outbreaks ###Unit of Measure: * Percent (%) ###Year: * 2007, 2012, 2015 ###Sources: * BKKBN - IDHS * BPS - SUSENAS KOR ###SDG Indicator: * __3.3__ By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases ###CPAP Outcome: * Child Survival and Development ###CPAP Output: * 1.5 EPI/Malaria/HIV


  • Added tag BPS to Percentage of children age 12-23 months who received Measles vaccine